163 related articles for article (PubMed ID: 38433191)
1. Efficacy of 5-fluorouracil (5-FU) and low molecular weight heparin (LMWH) in high-risk pediatric retinal detachment; randomized clinical trial.
Nasr M; Abdelhadi A; Bessa A; Ibrahim TM
BMC Ophthalmol; 2024 Mar; 24(1):97. PubMed ID: 38433191
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy in high-risk patients with retinal detachment: study protocol for a randomized controlled trial.
Schaub F; Hoerster R; Schiller P; Felsch M; Kraus D; Zarrouk M; Kirchhof B; Fauser S
Trials; 2018 Jul; 19(1):384. PubMed ID: 30012187
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy : Results from a randomized, double-blind, controlled clinical trial.
Asaria RH; Kon CH; Bunce C; Charteris DG; Wong D; Khaw PT; Aylward GW
Ophthalmology; 2001 Jul; 108(7):1179-83. PubMed ID: 11425671
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal 5-Fluorouracil and Heparin to Prevent Proliferative Vitreoretinopathy: Results from a Randomized Clinical Trial.
Schaub F; Schiller P; Hoerster R; Kraus D; Holz FG; Guthoff R; Agostini H; Spitzer MS; Wiedemann P; Lommatzsch A; Boden KT; Dimopoulos S; Bemme S; Tamm S; Maier M; Roider J; Enders P; Altay L; Fauser S; Kirchhof B;
Ophthalmology; 2022 Oct; 129(10):1129-1141. PubMed ID: 35680097
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery.
Sundaram V; Barsam A; Virgili G
Cochrane Database Syst Rev; 2013 Jan; (1):CD006421. PubMed ID: 23440808
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery.
Sundaram V; Barsam A; Virgili G
Cochrane Database Syst Rev; 2010 Jul; (7):CD006421. PubMed ID: 20614445
[TBL] [Abstract][Full Text] [Related]
7. Combined 5-fluorouracil, low-molecular-weight heparin, and silicone oil in the management of complicated retinal detachment with proliferative vitreoretinopathy grade C.
Garcia RA; Sanchez JG; Arevalo JF
Ophthalmic Surg Lasers Imaging; 2007; 38(4):276-82. PubMed ID: 17674917
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial of combined 5-Fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy.
Wickham L; Bunce C; Wong D; McGurn D; Charteris DG
Ophthalmology; 2007 Apr; 114(4):698-704. PubMed ID: 17398320
[TBL] [Abstract][Full Text] [Related]
9. Inferior retinotomy and silicone oil tamponade for recurrent inferior retinal detachment and grade C PVR in eyes previously treated with pars plana vitrectomy or scleral buckle.
Mancino R; Aiello F; Ciuffoletti E; Di Carlo E; Cerulli A; Nucci C
BMC Ophthalmol; 2015 Dec; 15():173. PubMed ID: 26645589
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathy.
Charteris DG; Aylward GW; Wong D; Groenewald C; Asaria RH; Bunce C;
Ophthalmology; 2004 Dec; 111(12):2240-5. PubMed ID: 15582080
[TBL] [Abstract][Full Text] [Related]
11. Pars plana vitrectomy versus scleral buckling for repairing simple rhegmatogenous retinal detachments.
Znaor L; Medic A; Binder S; Vucinovic A; Marin Lovric J; Puljak L
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD009562. PubMed ID: 30848830
[TBL] [Abstract][Full Text] [Related]
12. Pars plana vitrectomy and scleral buckle versus pars plana vitrectomy alone for patients with rhegmatogenous retinal detachment at high risk for proliferative vitreoretinopathy.
Storey P; Alshareef R; Khuthaila M; London N; Leiby B; DeCroos C; Kaiser R;
Retina; 2014 Oct; 34(10):1945-51. PubMed ID: 24999720
[TBL] [Abstract][Full Text] [Related]
13. Recurrent retinal detachment more than 1 year after reattachment.
Foster RE; Meyers SM
Ophthalmology; 2002 Oct; 109(10):1821-7. PubMed ID: 12359601
[TBL] [Abstract][Full Text] [Related]
14. Combined 5-Fluorouracil and Low Molecular Weight Heparin for the Prevention of Postoperative Proliferative Vitreoretinopathy in Patients With Retinal Detachment: A Meta-Analysis.
Chen C; Chen P; Liu X; Li H
Front Med (Lausanne); 2021; 8():790460. PubMed ID: 34917641
[No Abstract] [Full Text] [Related]
15. Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy.
Schwartz SG; Flynn HW; Lee WH; Wang X
Cochrane Database Syst Rev; 2014 Feb; 2(2):CD006126. PubMed ID: 24532038
[TBL] [Abstract][Full Text] [Related]
16. Strategy for the management of complex retinal detachments: the European vitreo-retinal society retinal detachment study report 2.
Adelman RA; Parnes AJ; Sipperley JO; Ducournau D;
Ophthalmology; 2013 Sep; 120(9):1809-13. PubMed ID: 23601805
[TBL] [Abstract][Full Text] [Related]
17. [Influencing factors of visual prognosis in patients with persistent submacular fluid after successful scleral buckle surgery for macula-off retinal detachment].
Chen YY; Tian B; He L; Li L; Li J; Shi XY; Zhou D
Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):899-905. PubMed ID: 37936358
[No Abstract] [Full Text] [Related]
18. Evaluation of Ab externo subretinal bands removal during pars plana vitrectomy for rhegmatogenous retinal detachment complicated by proliferative vitreoretinopathy.
Elbaha S; Ghoneem M; Abousamra A; Abouhussein M
BMC Ophthalmol; 2022 May; 22(1):227. PubMed ID: 35596163
[TBL] [Abstract][Full Text] [Related]
19. Combined pars plana vitrectomy-scleral buckle versus pars plana vitrectomy for proliferative vitreoretinopathy.
Lai FH; Lo EC; Chan VC; Brelen M; Lo WL; Young AL
Int Ophthalmol; 2016 Apr; 36(2):217-24. PubMed ID: 26260357
[TBL] [Abstract][Full Text] [Related]
20. VITREORETINAL SURGERY WITH SILICONE OIL TAMPONADE IN PRIMARY UNCOMPLICATED RHEGMATOGENOUS RETINAL DETACHMENT: Clinical Outcomes and Complications.
Antoun J; Azar G; Jabbour E; Kourie HR; Slim E; Schakal A; Jalkh A
Retina; 2016 Oct; 36(10):1906-12. PubMed ID: 26966864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
